Company profile for Frontier Medicine

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Frontier Medicines is a precision medicine company developing breakthrough medicines that redefine the course of debilitating diseases. Our focus is developing treatments against important disease-causing proteins that the biopharma industry hasn’t found a way to treat (or “drug”) with pharmaceutical interventions. After decades of research, this has become one of the most critical challenges in addressing human disease....
Frontier Medicines is a precision medicine company developing breakthrough medicines that redefine the course of debilitating diseases. Our focus is developing treatments against important disease-causing proteins that the biopharma industry hasn’t found a way to treat (or “drug”) with pharmaceutical interventions. After decades of research, this has become one of the most critical challenges in addressing human disease. At Frontier, we are deploying groundbreaking scientific approaches in chemoproteomics, covalent drug discovery, and machine learning to discover and pharmacologically target new binding pockets (or hotspots).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
151 Oyster Point Blvd., 2nd Floor South San Francisco, CA 94080
Telephone
Telephone
650-457-1005
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/04/28/3069599/0/en/Frontier-Medicines-Unveils-New-Preclinical-Data-for-FMC-220-a-First-in-Class-Covalent-p53-Y220C-Activator-at-AACR-2025.html

GLOBENEWSWIRE
28 Apr 2025

https://www.globenewswire.com/news-release/2025/02/27/3033809/0/en/Frontier-Medicines-to-Participate-in-Two-Upcoming-March-Investor-Conferences.html

GLOBENEWSWIRE
27 Feb 2025

https://www.globenewswire.com/news-release/2025/01/09/3007010/0/en/Frontier-Medicines-Announces-FMC-220-the-First-Covalent-p53-Y220C-Activator-Development-Candidate-with-Best-in-Class-Potential.html

GLOBENEWSWIRE
09 Jan 2025

https://www.globenewswire.com/news-release/2025/01/08/3006730/0/en/Frontier-Medicines-to-Present-at-the-43rd-Annual-J-P-Morgan-Healthcare-Conference.html

GLOBENEWSWIRE
08 Jan 2025

https://www.globenewswire.com/news-release/2024/07/23/2917078/0/en/Frontier-Medicines-Announces-Milestone-Payment-in-AbbVie-Partnership-Following-Advancement-of-Lead-Candidates-Targeting-a-Historically-Undruggable-Transcription-Factor.html

GLOBENEWSWIRE
23 Jul 2024

https://www.globenewswire.com/news-release/2024/06/25/2903654/0/en/Frontier-Medicines-Appoints-Gerardo-Ubaghs-as-Chief-Financial-Officer-and-Announces-20-Million-Series-C-Extension.html

GLOBENEWSWIRE
25 Jun 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty